Effects of ATX-MS-1467 immunotherapy over 16 weeks in relapsing multiple sclerosis

ATX-MS1467 Study Group, Guntis Karelis (Member of the Working Group)

Research output: Contribution to journalArticlepeer-review

67 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Effects of ATX-MS-1467 immunotherapy over 16 weeks in relapsing multiple sclerosis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science